Transjugular core liver biopsy with a 19-gauge spring-loaded cutting needle

Obtaining liver tissue in patients with coagulopathy or ascites poses a challenge. Traditional percutaneous methods carry bleeding risks. Transjugular approaches may reduce these risks. Prior research has shown that transjugular techniques can access the liver via the jugular vein. However, the success rates and safety of specific tools remain unclear. This gap motivated a study to assess the 19-gauge QCB needle for TJLBx. No prior work had resolved the effectiveness of this specific device in such patients. The study aimed to determine if this approach could reliably yield diagnostic samples.

The study aimed to evaluate the diagnostic yield and safety of transjugular core liver biopsy using the 19-gauge QCB needle. The specific problem was whether this tool could provide sufficient tissue in patients with coagulopathy or ascites. The motivation was to find a safer alternative to percutaneous biopsy. The researchers proposed that the QCB needle could improve success rates while minimizing complications. No prior work had tested this device in such a population. The goal was to measure both procedural success and diagnostic accuracy. The study also sought to identify any major adverse events.

The study involved 101 patients undergoing 105 transjugular liver biopsies. The primary tool was the 19-gauge QCB needle. Biopsies were performed sequentially in patients with coagulopathy or ascites. A total of 295 passes were attempted to collect tissue. The number of cores obtained was recorded per pass. Histopathologic diagnosis was the main outcome measure. Complications were tracked and categorized. The study used a retrospective analysis of clinical records.

The procedure yielded 273 cores from 295 passes, a success rate of 92.5%. Ninety-seven percent of procedures led to a histopathologic diagnosis. Three biopsies were nondiagnostic, with one due to tissue autolysis. Only one death occurred, unrelated to the procedure. Adverse events included one subcapsular hematoma and one arteriovenous fistula. Minor neck hematomas occurred twice. The diagnostic yield was high despite patient risk factors. The complication rate was low compared to percutaneous methods.

The authors stated that the QCB needle is effective for transjugular liver biopsy in high-risk patients. The study suggests that this method can provide diagnostic samples with acceptable safety. No essential role of the needle was claimed, but the results support its use. The findings align with prior work on transjugular approaches. The authors propose that this technique is a viable alternative to percutaneous biopsy. The study does not claim superiority over other devices. The results are specific to the 19-gauge QCB needle. The authors do not generalize beyond the study population.